SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-217368
Filing Date
2022-08-10
Accepted
2022-08-10 16:15:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d312777d424b5.htm 424B5 554638
2 GRAPHIC g312777g03y28.jpg GRAPHIC 47951
3 GRAPHIC g312777g38c83.jpg GRAPHIC 185827
  Complete submission text file 0001193125-22-217368.txt   870864
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260945 | Film No.: 221151997
SIC: 2834 Pharmaceutical Preparations